Optimizing and Accelerating Medical Device Regulatory Approvals with AI and RWiD
Artificial intelligence (AI) and real-world imaging data (RWiD) are fundamentally reshaping and accelerating regulatory approval for medical devices. By delivering more effective, accurate, and transparent regulatory efficiency to a historically manual, slow-motion approach, AI and RWiD are fundamentally changing the regulatory landscape. AI gives the ability to automate functions, reliability, predict, and approve compliance in near real-time, ultimately shortening approval time and error rate. RWiD integrates all of this rich, real-world data into the regulatory review process, amplifying confidence in the safety and effectiveness of devices, while allowing for expedited access to the marketplace. Ultimately, the administrative functions of device development, or regulatory submissions, are transformed by the convergence of AI and RWiD. Market access, innovation, and patient outcomes are all measurably enhanced through monitoring of device performance, clinical utility, and automatic...